01 January 2002
Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
Mandira Mukherjee, Anindita Bhattacharyya, Swadesh DuttaguptaMed Sci Monit 2002; 8(4): BR117-122 :: ID: 420881
Abstract
BACKGROUND: The serodiagnosis of visceral leishmaniasis due to Leishmaniadonovani using crude parasite antigen is complicated in many endemic areas by cross-reactions with serumfrom humans infected with other protozoan diseases. The search for pure antigens avoiding such cross-reactionsis in progress. Developing a vaccine against cutaneous leishmaniasis has been much more successful thanagainst visceral leishmaniasis. Immunoprophylactic studies using various combinations of antigens andadjuvants are also in progress, and several strategies are in use, with varying degrees of success. MATERIAL/METHODS:Promastigotes of Leishmania donovani were used. The 78kDa protein was purified by a monoclonal antibodytagged CNBr sepharose CL-4B column. The presence of the protein in both stages of the parasite and inkala-azar patient serum was analyzed by western blotting. ELISA was used for serodiagnosis and isotypeanalysis of antibodies produced in immunized mice. Immunoprophylactic studies were carried out basedon in vitro transformation of amastigotes to promastigotes. RESULTS: The 78 kDa membrane protein, presentin both amastigote and promastigote forms of the parasite, was purified to homogeneity. The protein wasfound to have serodiagnostic potential to detect kala-azar. BALB/c mice immunized with 78kDa proteinrevealed reduction in spleen parasitemia. Isotype profiles of antibodies produced by immunized mice showedincreased production of IgG2a and decreased IgG1 levels. CONCLUSIONS: Our results demonstrated, for thefirst time, the serodiagnostic and immunoprophylactic use of a pure membrane protein isolated from Leishmaniadonovani of Indian origin.
Keywords: Antibodies, Monoclonal, Antibodies, Protozoan, Antigens, Protozoan, Immunoglobulin G, Immunoglobulin Isotypes, Immunoglobulin M, India, Leishmania donovani, Leishmaniasis, Visceral, Membrane Proteins, Molecular Weight, Parasitemia, Protozoan Proteins, Protozoan Vaccines, Vaccination
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952